Evidence map›Paper›PMID 42619836›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Surveying the Genomic Landscape of Mantle Cell Lymphoma Indicates the Importance of Multimodal Genomic and Transcriptomic Exploration.

Charlz Nithin Jerold, Brian Li, Matthew Mosior, David Russler-Germain, Anshu Dahal, Zachary Skidmore, Kelsy C Cotto, Malachi Griffith, Todd A Fehniger, Obi L Griffith and 2 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Charlz Nithin JeroldWashington University School of Medicine, Department of Medicine, St. Louis, MO 63108.ORCID 0009-0008-8568-7193
Brian LiWashington University School of Medicine, Department of Medicine, St. Louis, MO 63108.
Matthew MosiorWashington University School of Medicine, Department of Medicine, St. Louis, MO 63108.
David Russler-GermainWashington University School of Medicine, Department of Medicine, St. Louis, MO 63108.
Anshu DahalWashington University School of Medicine, Department of Medicine, St. Louis, MO 63108.
Zachary SkidmoreWashington University School of Medicine, Department of Medicine, St. Louis, MO 63108.
Kelsy C CottoWashington University School of Medicine, Department of Medicine, St. Louis, MO 63108.ORCID 0000-0003-0890-6889
Malachi GriffithWashington University School of Medicine, Department of Medicine, St. Louis, MO 63108.
Todd A FehnigerWashington University School of Medicine, Department of Medicine, St. Louis, MO 63108.
Obi L GriffithWashington University School of Medicine, Department of Medicine, St. Louis, MO 63108.ORCID 0000-0002-0843-4271
Brad KahlWashington University School of Medicine, Department of Medicine, St. Louis, MO 63108.
Felicia GomezWashington University School of Medicine, Department of Medicine, St. Louis, MO 63108.ORCID 0000-0003-4884-7510

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Paul Calabresi K12 Career Development Award for Clinical OncologyK12CA167540 · NCI · WASHINGTON UNIVERSITY · PI John F. Dipersio, Ramaswamy Govindan · 2012 to 2026
$11.7M
Informatics tools for identification, prioritization and clinical application of neoantigensU01CA248235 · NCI · WASHINGTON UNIVERSITY · PI GRIFFITH, MALACHI · 2020 to 2022
$1.3M
Deep Sequencing of Relapse and Refractory Hodgkin Lymphoma Genomes: A Study of Tumor Biology and EvolutionK22CA266743 · NCI · WASHINGTON UNIVERSITY · PI GOMEZ, FELICIA · 2023 to 2025
$583k
INTEGRATED ANALYSIS & INTERPRETATION OF WHOLE GENOME, EXOME & TRANSCRIPTOME SEQUENCE DATA IN CANCERK99HG007940 · NHGRI · WASHINGTON UNIVERSITY · PI GRIFFITH, MALACHI · 2015 to 2016
$264k
NCATS NIH HHS UL1 TR002345NCI NIH HHS K12 CA167540NCI NIH HHS K22 CA266743NCI NIH HHS P30 CA091842NCI NIH HHS U01 CA248235NHGRI NIH HHS K99 HG007940
6 · The paper itself

Abstract

Mantle cell lymphoma (MCL) is a B-cell non-Hodgkin lymphoma characterized by heterogeneous clinical courses despite a common pathobiological initiating event. In this work we explore the genomic variants that characterize MCL and integrate transcriptomic data to comprehensively describe MCL biology. We performed whole exome sequencing (WES) on 28 tumor-normal pairs (lymph node and skin, respectively), as well as whole genome sequencing (WGS) and RNA sequencing on subsets of samples. We used established DNA and RNA analysis pipelines to detect single-nucleotide variants (SNV) and indels, structural variants, copy-number alterations, and RNA fusions. The canonical t(11;14)(q13;q32)

Indexed as

exomeMantle cell lymphomaRNA-seqwhole genome sequencing

Identifiers

PMID42619836
PMCPMC13484329

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.